FTFinancial Times·19hBusiness
score+0.60
AstraZeneca highlights rare diseases in $80bn revenue push
Original
AstraZeneca highlights rare diseases in $80bn revenue push
“Forward-looking business strategy emphasizing growth opportunity and untapped market potential with constructive, confident framing.”